Skip to content

LabGenius Therapeutics vs Valink Therapeutics

LabGenius Therapeutics logo

LabGenius Therapeutics

Combining human and machine intelligence to discover the next generation of therapeutic antibodies

63 employees · est. 2012 · London, United Kingdom

VS
Valink Therapeutics logo

Valink Therapeutics

Making better ADCs

31 employees · est. 2020 · Cambridge, United States

LabGenius Therapeutics is the older company (2012 vs 2020); LabGenius Therapeutics is the larger of the two.

Side-by-Side Comparison

LabGenius Therapeutics Valink Therapeutics
Founded
2012 older 2020
Headquarters
London, United Kingdom Cambridge, United States
Employees
63 larger 31
Industry
AI, Biotechnology, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Series B Seed
Total Funding
$63.66M Not tracked yet
Funding Rounds
6 2
Services
Therapeutic Antibody Discovery, Multispecific Antibody Development, AI and Machine Learning Integration Drug Discovery and Development, Therapeutic Design and Optimization, Biologics Research, Pipeline Development
Target Customers
Pharmaceutical Companies, Biotech Research Organizations, Healthcare Providers Pharmaceutical Companies, Biotech Researchers, Medical Professionals, Cancer Treatment Facilities, Healthcare Institutions
Taxonomy
Therapeutic AntibodiesDrug DiscoveryRobotic AutomationSynthetic BiologyProtein TherapeuticsAntibody Engineering +6 Antibody-Drug ConjugatesBsADCsPlatform TherapeuticsOncologySolid TumorsMultivalent Antibodies +7
Website
labgeniustx.com valinktx.com
LabGenius Therapeutics logo

About LabGenius Therapeutics

LabGenius Therapeutics, founded in 2012, is a drug discovery company based in the United Kingdom. It focuses on the development of next-generation therapeutic antibodies utilizing its advanced EVA™ platform, which combines artificial intelligence, robotic automation, and synthetic biology. This plat...

Valink Therapeutics logo

About Valink Therapeutics

Valink Therapeutics, with its slogan "Making better ADCs," is pioneering the development of novel multivalent bispecific antibody-drug conjugates (bsADCs) designed to revolutionize the treatment of solid tumors and other critical health conditions. The company's innovative approach focuses on non-ob...

Also comparing in this category

Comparing more than these two?

Get LabGenius Therapeutics, Valink Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does LabGenius Therapeutics compare?

A PDF of LabGenius Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

LabGenius Therapeutics was founded in 2012, based in London, United Kingdom, with 63 employees. LabGenius Therapeutics, founded in 2012, is a drug discovery company based in the United Kingdom. It focuses on the development of next-generation therapeutic antibodies utilizing its advanced EVA™ pl. Valink Therapeutics was founded in 2020, based in Cambridge, United States, with 31 employees. Valink Therapeutics, with its slogan "Making better ADCs," is pioneering the development of novel multivalent bispecific antibody-drug conjugates (bsADCs) designed to revolutionize the treatment of so.
LabGenius Therapeutics has raised $63.66M and Valink Therapeutics no disclosed funding. Latest stage: LabGenius Therapeutics Series B, Valink Therapeutics Seed.
Both work in Biotechnology and Health and Wellness and list solid tumors among their focus areas.

Compare LabGenius Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at LabGenius Therapeutics on 15 Jun 2026, and Valink Therapeutics on 22 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout